Keywords: PCa، سرطان پروستات; prostatic neoplasms; prostatectomy; aged; aged, 80 and over; outcome assessment, (health care)ADT, androgen deprivation therapy; ASA®, American Society of Anesthesiologists®; BCR, biochemical recurrence; LE, life expectancy; PCa, prostate cancer; PSA, pro
مقالات ISI PCa، سرطان پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: PCa، سرطان پروستات; prostate; prostate specific antigen; mass screening; African American; educationHCP, health care provider; NHW, nonHispanic white; PCa, prostate cancer; PSA, prostate specific antigen; USPSTF, United States Preventive Services Task Force
Keywords: PCa، سرطان پروستات; prostatic neoplasms; age groups; mortality; prostate cancer; riskCCI, Charlson comorbidity index; CSM, cancer specific mortality; OCM, other cause mortality; PCa, prostate cancer; PSA, prostate specific antigen; RP, radical prostatectomy
Keywords: PCa، سرطان پروستات; prostatic neoplasms; prostate-specific antigen; risk factors; mass screeningERSPC, European Randomized Study of Screening for Prostate Cancer; PCa, prostate cancer; PSA, prostate specific antigen
Keywords: PCa، سرطان پروستات; prostatic neoplasms; biopsy; ultrasonography; magnetic resonance imaging; diagnostic imaging3D, 3-dimensional; MRI, magnetic resonance imaging; PCa, prostate cancer; STD, standard; TAR, targeted; TRUS, transrectal ultrasound; US, ultrasound
Keywords: PCa، سرطان پروستات; prostatic neoplasms; mortality; prostate-specific antigen; mass screening; European continental ancestry groupBMI, body mass index; FH, family history; PCa, prostate cancer; PLCO, Prostate, Lung, Colorectal and Ovarian; PSA, prostate specific antigen
Keywords: PCa، سرطان پروستات; prostatic neoplasms; neoplasm recurrence; local; lymph node dissection; radiotherapy; salvage therapyADT, androgen deprivation therapy; CT, computerized tomography; PCa, prostate cancer; PET, positron emission tomography; RT, radiotherapy; sLND, salvage l
Keywords: PCa، سرطان پروستات; prostatic neoplasms; prostate-specific antigen; mass screening; risk; prognosisc-index, concordance index; DRE, digital rectal examination; PCA, prostate cancer; PSA, prostate specific antigen; SABOR, San Antonio Biomarkers of Risk for Prostate Cancer
Keywords: PCa، سرطان پروستات; neoplasm grading; neoplasm staging; prostatic neoplasms; SEER program; watchful waitingAOR, adjusted odds ratio; AS, active surveillance; MRI, magnetic resonance imaging; MVA, multivariable logistic regression analysis; PCa, prostate cancer; PPC, percent
Keywords: PCa، سرطان پروستات; prostate; adenocarcinoma; neoplasm staging; risk; prognosisDCE, dynamic contrast enhanced; ECE, extracapsular extension; MP, multiparametric; MRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; RP, radical prostatectomy;
Keywords: PCa، سرطان پروستات; prostatic neoplasms; early detection of cancer; magnetic resonance imaging; elasticity imaging techniques; prostatectomyMRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; SWE, shear wave elastography; TRUS, transrectal
Keywords: PCa، سرطان پروستات; prostatic neoplasms; prostate-specific antigen; prostatectomy; neoplasm recurrence; local; diagnosisBCR, biochemical recurrence; ePSADT, early PSADT; LLD, lower detection limit; PCa, prostate cancer; PPV, positive predictive value; PSA, prostate specific
Keywords: PCa، سرطان پروستات; prostate; prostatic neoplasms; SEER program; risk; trendsADT, androgen deprivation therapy; CCI, Deyo-Charlson comorbidity index; NCDB, National Cancer Database; NCIM, noncurative initial management; NOS, not otherwise specified; PCa, prostate cancer; PSA
Keywords: PCa، سرطان پروستات; magnetic resonance imaging; biopsy; prostatic neoplasmsDRE, digital rectal examination; GS, Gleason score; mp-MRI, multiparametric magnetic resonance imaging; MRI, magnetic resonance imaging; PCa, prostate cancer; PI-RADS, Prostate Imaging Reporting and D
Keywords: PCa، سرطان پروستات; EChT, electrochemical therapy; PCa, prostate cancer; PSA, prostate specific antigen; s.c, subcutaneous; U, voltage; T, temperature; Pt–Ir, Platinum–Iridium; CD, current density; RFS, recurrence-free survival; HR, hazard ratioProstate cancer; Prostate tumo
Keywords: PCa، سرطان پروستات; prostatic neoplasms; testosterone; hypogonadism; neoplasm recurrence; local; prognosisAR, androgen receptor; DHT, dihydrotestosterone; DRE, digital rectal examination; FT, free testosterone; PCa, prostate cancer; PSA, prostate specific antigen; SHBG, sex
Keywords: PCa، سرطان پروستات; prostatic neoplasms; neoplasm recurrence; local; radiotherapy; urinary bladder neoplasms; cystectomyBCR, biochemical recurrence; EBRT, external beam RT; PCa, prostate cancer; PSA, prostate specific antigen; RC, radical cystectomy; RT, radiotherapy
Keywords: PCa، سرطان پروستات; prostate; prostatic neoplasms; quality of life; biopsy; cryotherapy3D, 3-dimensional; 3DMB, 3D mapping biopsy; AS, active surveillance; AUA-SS, American Urological Association symptom score; PCa, prostate cancer; SHIM, Sexual Health Inventory for Men; TFT
Keywords: PCa، سرطان پروستات; AUC, area under the curve; bioT, bioavailable testosterone; %CV, percent coefficients of variation; fPSA, free PSA; fT, free testosterone; %fT, fraction (%) of free testosterone; NEM, no evidence of malignancy; %fPSA, % free PSA; PCa, prostate cancer; PCA
Keywords: PCa، سرطان پروستات; prostate; prostatic neoplasms; Asian Americans; epidemiology; SEER programFB, foreign born; GS, Gleason score; NH, nonHispanic; PCa, prostate cancer; PSA, prostate specific antigen; SES, socioeconomic status; USB, United States born
Keywords: PCa، سرطان پروستات; PSA, prostate-specific antigen; PCa, prostate cancer; SNP, single nucleotide polymorphism; GWAS, genome-wide association study; ICSNPathway, the identify candidate causal SNPs and pathways; CYP26B1, cytochrome P450, family 26, subfamily B, polypeptide 1;
Keywords: PCa، سرطان پروستات; prostate; prostatic neoplasms; biological markers; exosomes; gene expressionBDL, below analytical detection limit; DNase, deoxyribonuclease; DRE, digital rectal examination; PCa, prostate cancer; PCA3, PCa antigen 3; PCR, polymerase chain reaction; PSA, p
Keywords: PCa، سرطان پروستات; Prostate cancer; Obesity; Biological mechanisms; Overweight; BMIBMI, body mass index; WHO, World Health Organization; PCa, prostate cancer; PSA, prostate-specific antigen; RP, radical prostatectomy; DRE, digital rectal examination; CT, computed tomography
Keywords: PCa، سرطان پروستات; prostate; prostatic neoplasms; African Americans; risk; neoplasm gradingAA, black; AS, active surveillance; BMI, body mass index; GS, Gleason score; MRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; PSAD, PSA density;
Keywords: PCa، سرطان پروستات; PCa, prostate cancer; PSA, prostate specific antigen; DRE, digital rectal examination; TRUS, transrectal ultrasound; PCA3, Prostate Cancer Antigen 3; TMPRSS2, Transmembrane Protease, Serine 2; CTC, circulating tumour cell; mRNA, messenger RNA; PPV, positi
Keywords: PCa، سرطان پروستات; miRNAs, MicroRNAs; BPH, Benign prostatic hyperplasis; PCa, Prostate cancer; PSA, Prostate specific antigen; AR, Androgen receptor; PRDX1, Peroxiredoxin 1; q RT-PCR, Quantitative real time PCR; M, Methylated; U, UnmethylatedProstate cancer; miRNAs; miR-510
Keywords: PCa، سرطان پروستات; prostatic neoplasms; aged; standard of care; watchful waiting; SEER programAS, active surveillance; MRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; WW, watchful waiting
Keywords: PCa، سرطان پروستات; prostatic neoplasms; histology; age factorsBPH, benign prostatic hyperplasia; GS, Gleason score; HE, hematoxylin and eosin; PCa, prostate cancer; PSA, prostate specific antigen
Keywords: PCa، سرطان پروستات; prostatic neoplasms; 25-hydroxyvitamin D; biomarkers; neoplasm grading; prognosisNEM, no evidence of malignancy; PCa, prostate cancer; PSA, prostate specific antigen; VitD, 25-hydroxyvitamin D
Keywords: PCa، سرطان پروستات; prostatic neoplasms; magnetic resonance imaging; image-guided biopsympMRI, multiparametric magnetic resonance imaging; MR-F, magnetic resonance-ultrasound fusion; MRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; ROI,
Keywords: PCa، سرطان پروستات; prostatic neoplasms; prostatectomy; robotic surgical procedures; health care costs; health servicesCCI, Charlson comorbidity index; MVA, multivariate analysis; PCa, prostate cancer; RARP, robot-assisted radical prostatectomy; RP, radical prostatectomy
Keywords: PCa، سرطان پروستات; prostatic neoplasms; disease progression; watchful waiting; African Americans; early detection of cancerADT, androgen deprivation therapy; AS, active surveillance; AT, active treatment; KPNC, Kaiser Permanente Northern California; PCa, prostate cancer; PS
Keywords: PCa، سرطان پروستات; prostatic neoplasms; ultrasonography; biopsy; diagnostic imaging; disease progressionAS, active surveillance; DRE, digital rectal examination; MRI, magnetic resonance imaging; PCa, prostate cancer; PSA, prostate specific antigen; TRUS, transrectal ultraso
Keywords: PCa، سرطان پروستات; biomarkers; prostate cancer antigen 3; human; prostatic neoplasms; African Americans; biopsyAA, African-American; CA, Caucasian American; DCA, decision curve analysis; DRE, digital rectal examination; PCa, prostate cancer; PSA, prostate specific antigen;
Frequency of PTEN alterations, TMPRSS2-ERG fusion and their association in prostate cancer
Keywords: PCa، سرطان پروستات; PTEN, phosphatase and tensin homolog; TMPRSS2, trans membrane protease, serine 2; ERG, erythroblastosis virus E26 oncogene homolog; PCA, prostate cancer; FISH, fluorescent in situ hybridization; PSA, prostate-specific antigenPTEN; TMPRSS2-ERG; Prostate ca
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort
Keywords: PCa، سرطان پروستات; prostatic neoplasms; prospective studies; watchful waitingAS, active surveillance; BMI, body mass index; EPE, extraprostatic extension; NCCN®, National Comprehensive Cancer Network®; PASS, Prostate cancer Active Surveillance Study; PCa, prostate cancer; P
Assessment of Prospectively Assigned Likert Scores for Targeted Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsies in Patients with Suspected Prostate Cancer
Keywords: PCa، سرطان پروستات; early detection of cancer; risk assessment; prostatic neoplasms; biopsy; magnetic resonance imagingDRE, digital rectal examination; mp, multiparametric; MRI, magnetic resonance imaging; PCa, prostate cancer; PI-RADS, Prostate Imaging Reporting and Data Sy
Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile
Keywords: PCa، سرطان پروستات; prostatic neoplasms; DNA methylation; castration; androgens; epigenomicsAD, androgen deprivation; AR, androgen receptor; CRPC, castration resistant PCa; NE, neuroendocrine; PCa, prostate cancer; PSA, prostate specific antigen; ZNF, zinc finger
Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer
Keywords: PCa، سرطان پروستات; PCa, prostate cancer; UGT, UDP-glucuronosyltransferase; DHT, dihydrotestosterone; miRNA, microRNA; 3′UTR, 3′-untranslated region; MRE, miRNA recognition element; RT-qPCR, reverse transcription-quantitative PCRmiRNA; Prostate cancer; UDP-glucuronosyltransf
Catalase C-262T polymorphism and risk of prostate cancer: Evidence from meta-analysis
Keywords: PCa، سرطان پروستات; CAT, catalase; PCa, prostate cancer; OR, odds ratios; CI, confidence intervals; GWAS, genome-wide association studies; MPO, myeloperoxidase; SOD2, superoxide dismutase; ROS, reactive oxygen speciesCatalase; Polymorphism; Prostate cancer; Meta-analysis
Multiple roles for udp-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution
Keywords: PCa، سرطان پروستات; AR, androgen receptor; ADT, androsterone; CRPC, castrate resistant/refractory prostate cancer; DHEA, dehydroepiandrosterone; 3α-DIOL, androstane-3α-DIOL; DHT, dihydrotestosterone; G, glucuronide; PCa, prostate cancer; UGT, UDP-glucuronosyltransferase; V,
Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes
Keywords: PCa، سرطان پروستات; watchful waiting; neoplasm grading; disease progression; prostatic neoplasmsAS, active surveillance; BXn, biopsy number after initial upgrade; GS, Gleason score; PCa, prostate cancer; PSA, prostate specific antigen; PSAD, PSA density; PSM, positive surgic
Baseline Perineural Invasion is Associated with Shorter Time to Progression in Men with Prostate Cancer Undergoing Active Surveillance: Results from the REDEEM Study
Keywords: PCa، سرطان پروستات; prostatic neoplasms; disease progression; prostate-specific antigen; neoplasm invasiveness; riskAS, active surveillance; BMI, body mass index; DRE, digital rectal examination; PCa, prostate cancer; PNI, perineural invasion; PSA, prostate specific antigen
Outcomes of Ventral Onlay Buccal Mucosa Graft Urethroplasty in Patients after Radiotherapy
Keywords: PCa، سرطان پروستات; urethral stricture; prostatic neoplasms; mouth mucosa; autografts; radiotherapyAUS, artificial urinary sphincter; BMGU, buccal mucosa graft urethroplasty; EPA, stricture excision and primary reanastomosis; PCa, prostate cancer; Qmax, maximum flow rate; RT
The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case–control studies
Keywords: PCa، سرطان پروستات; MTHFR, methylenetetrahydrofolate reductase; PCa, prostate cancer; MeSH, Medical Subject Heading; OR, odds ratio; CI, confidence intervals; HWE, Hardy–Weinberg equilibrium; PCR-RELP, PCR restriction fragment length polymorphism; SNP, single nucleotide poly
cfDNA as a Prognostic Marker of Response to Taxane Based Chemotherapy in Patients with Prostate Cancer
Keywords: PCa، سرطان پروستات; prostatic neoplasms; taxane; DNA; prognosis; mortalitycfDNA, cell-free DNA; CRPCA, castration resistant PCA; CTC, circulating tumor cell; Hb, hemoglobin; LDH, lactate dehydrogenase; PCA, prostate cancer; PSA, prostate specific antigen
Effect of the USPSTF Grade D Recommendation against Screening for Prostate Cancer on Incident Prostate Cancer Diagnoses in the United States
Keywords: PCa، سرطان پروستات; prostatic neoplasms; mass screening; prostate-specific antigen; guideline; diagnosisCoC, Commission on Cancer; PCa, prostate cancer; PSA, prostate specific antigen
Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men
Keywords: PCa، سرطان پروستات; prostate; prostatic neoplasms; biopsy; prostate-specific antigen; nomogramsDRE, digital rectal examination; EDRN, Early Detection Research Network; fPSA, free PSA; p2PSA, [−2]proPSA serum isoform; PCa, prostate cancer; PHI, Prostate Health Index; PSA, pro
Prospective Evaluation of Magnetic Resonance Imaging Guided In-bore Prostate Biopsy versus Systematic Transrectal Ultrasound Guided Prostate Biopsy in Biopsy Naïve Men with Elevated Prostate Specific Antigen
Keywords: PCa، سرطان پروستات; prostate; prostatic neoplasms; biopsy; magnetic resonance imaging; ultrasonographyFOV, field of view; MR, magnetic resonance; MRI, MR imaging; PCa, prostate cancer; PSA, prostate specific antigen; START, Standards of Reporting for MRI-Targeted Biopsy Stud
Structural characterization of P1′-diversified urea-based inhibitors of glutamate carboxypeptidase II
Keywords: PCa، سرطان پروستات; BBB, blood–brain barrier; GCPII, glutamate carboxypeptidase II; NAAG, N-acetyl-aspartyl-glutamate; QM, quantum mechanics; PCa, prostate cancer; SAR, structure-activity relationshipGCPII; Prostate-specific membrane antigen; PSMA; Metallopeptidase; X-ray cr